Note 6 - Other Assets
|12 Months Ended|
Mar. 31, 2020
|Notes to Financial Statements|
|Other Assets Disclosure [Text Block]||
The Corporation owns a reserve of krill oil in which amounts are expensed as it is used. The following table summarizes information regarding activities of amounts of the krill oil usage in the research and development production processes and for
NKPL66(the active pharmaceutical ingredient for CaPre) manufacturing.
The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.
No definition available.